global

The Sebacic Acid Market Will Record Remuneration of $620 Million by 2026, Says Global Market Insights Inc.

The growth of the global sebacic acid market is accelerated significantly owing to higher bio-based polymer production and consumption levels, given its ecological advantages, according to this report.
Press Release – updated: Jan 20, 2020 04:30 EST

SELBYVILLE, Del., January 20, 2020 (Newswire.com) – According to the report published by Global Market Insights, Inc., the global sebacic acid market was estimated at $385 million in 2018 and is expected to hit $620 million by 2026, registering a CAGR of 5.5% from 2019 to 2026. The report contains a detailed study of market size and estimations, key revenue pockets, major strategies, growth drivers and prospects, competitive landscape as well as fluctuations in market trends.
Shifting customer preferences towards bio-lubricants over traditional, owing to lower carbon emissions and strict regulatory policies are expected to present lucrative growth prospects for the sebacic acid market. Steady financial support in the automotive sector for the development of fuel-efficient, high-performance vehicles, alongside rising consumer expenditure will foster product demand. Sebacic acid is used extensively in the production of myriad products across diverse applications including lubricants, plasticizers, chemical intermediates and adhesives, due to its corrosion inhibition and low-temperature characteristics.
Request sample report at https://www.gminsights.com/request-sample/detail/294
Favorable regulatory initiatives, like REACH by European Chemical’s Agency, has categorized sebacic acid as safe for humans, which will add impetus to sebacic acid market growth. Industry expansion is further accelerated owing to the escalating utilization of eco-friendly substances among the population, given its production from castor oil.
Key reasons for sebacic acid market growth:
The paradigm shift towards sebacic acid over petroleum-based solvents
Escalating demand for dibutyl sebacate across various application segments 
Consistent R&D efforts by key industry players for advanced incorporation of the product.
The plasticizers application to dominate to 2026
Based on the application, the sebacic acid market is categorized into plasticizers, lubricants, adhesives, solvents, and chemical intermediates segments. Among these, the plasticizer segment holds the dominant position and is anticipated to exhibit the fastest growth rate during the forecast period.
Increasing construction efforts in China towards the development of diverse building components including film & sheet coverings, wires & cables and wall & flooring will bolster demand for plasticizer application in the region. Revenue from the construction industry in China is poised to achieve a valuation of over $1 trillion by 2022, in turn presenting several growth prospects for the sebacic acid industry from the plasticizer segment. This growth is largely attributed to favorable government strategies such as “One Belt One Road”, which aims to link China with the western world, through the development of roads, railways and other infrastructures.
North America to maintain its hold during the forecast period
The sebacic acid market across North America held a high share in 2018 and is expected to rule the roost throughout the study period, owing to rising living standards which has led to increasing expenditure on cosmetics. However, the Asia Pacific region is likely to account for a notable share from 2019 to 2026, owing to the rising business of automotive manufacturing units in the region.
Make an inquiry for purchasing this report: https://www.gminsights.com/inquiry-before-buying/294
Leading market players
Leading market players analyzed in the research include Hokoku Corporation, Tokyo Chemical Industry, BASF SE, KGN Enterprises, Wilmar and Arkema. These companies are focused on implementing expansive R&D activities to encourage product innovations that deliver superior properties like hydrophobicity, ductility, flexibility, and advanced lower melting temperatures.
About Us:
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities, and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities. Global Market Insights publishes high quality, in-depth market research studies, to help clients obtain granular level clarity on current business trends and expected future developments. We are committed to our client’s needs, providing custom solutions best fit for strategy development and implementation to extract tangible results.
Contact Us:Global Market Insights, Inc.4 North Main StreetSelbyville, Delaware 19975 USA​Phone: 1-302-846-7766Toll-Free: 1-888-689-0688Website: https://www.gminsights.com​Email: sales@gminsights.com
Source: Global Market Insights, Inc.

Surrogacy is Increasingly Accepted as Just One More Way to Grow a Family, says Global Surrogacy Services

All kinds of people are now taking advantage of gestational surrogacy to grow their families.

Families turn to surrogacy for a number of reasons and it’s crucial all involved have the information they need to make an informed decision.

LOS ANGELES (PRWEB) January 18, 2020
A December 24 article in The Salt Lake Tribune reports on the growing acceptance of surrogacy and the safeguards that are increasingly protecting everyone involved in the process of bringing a new child into the world. Naturally, the parental journey looks different for every family, and the article discusses the importance of careful consideration before entering into the surrogacy process, both for intended parents and potential gestational surrogates. As the article mentions, families turn to surrogacy for a number of reasons and it’s crucial all involved have the information they need to make an informed decision. Global Surrogacy Services says that one of its main goals is to provide intended parents and surrogates all of the necessary information needed to make a truly informed decision.
Global Surrogacy Services states that its team of highly experienced medical and legal professionals covers an extremely wide range of tasks. These include selecting the very best fertility specialists and obstetricians as well as finding the knowledgeable legal professions needed to navigate each aspect of the surrogacy journey appropriately. The firm adds that one of its most important offerings is its highly detailed screening process for women who are interested in becoming surrogates, which includes both physical and psychological screening. To become a surrogate is a life-changing decision and requires a special kind of woman who truly wants to help a family know the joy of parenthood and who is also physically and mentally ready to do so, says the agency.
Intended parents, as well as potential surrogates, will be interested in the basic requirements for a woman to become a surrogate with Global Surrogacy Services. Women should be between the ages of 21 to 38, must have previously given birth without complications, and must currently have a child at home. Naturally, it is also a requirement that the gestational surrogate is a non-smoker with a smoke-free household, has no history of substance abuse and must live in a generally safe and healthy environment. Of course, having a child under any circumstances is no small task and surrogates are compensated for their effort and time, says the agency. It notes that former-surrogates often take advantage of their windfall to make significant improvements in their lives such as going back to school or buying a long-needed family car.
As for intended parents, Global Surrogacy Services says that, while some intended parents try to go it alone, the medical and legal complexities involved with arranging a gestational surrogacy makes that not only a herculean task but one fraught with potential risks. With any task this complicated, it is best to allow professionals who understand the details handling the process. The agency notes that it has helped couples and individuals of all walks of life and orientations enjoy a smooth and fulfilling parental journey.
For further information, call Global Surrogacy Services at (800) 355-2009 or visit its website at https://www.globalsurrogacyservices.com/.

Share article on social media or email:

Mahavir Sharma Appointed as Chairman of the TiE Global Board of Trustees

Three New Trustees Elected to the TiE Global Board; Dinesh Dhamija Appointed as Vice Chairman
Press Release – updated: Jan 17, 2020 12:00 PST

SANTA CLARA, Calif., January 17, 2020 (Newswire.com) –  ​The TiE Global Board of Trustees recently announced that Mahavir Pratap Sharma has been elected as the Chairman of the Board of TiE Global.
Jaipur-based entrepreneur and investor Mahavir Sharma was the Vice-Chairman of TiE Global in 2019. Additionally, he is also the Chairman of TiE India Angels, a pan-India angel group, launched last year. Sharma is also the founder and chairman of Rajasthan Angels (RAIN).
The TiE Global Board of Trustees also elected Dinesh Dhamija as its Vice-Chairman. London-based Dinesh Dhamija was the founder of the online travel platform E-bookers, which he sold in 2005. He is currently the Deputy Treasurer of the Liberal Democratic Party and was recently elected as a Member of the European Parliament representing the London constituency.
TiE Global Chair, Mahavir Sharma said his priority is to make TiE an organization that is of profound value to existing members but also to the future and younger startup community, by strengthening its existing outreach programs for school students (TYE), college students (TiE Univ), women entrepreneurs (TiE Women) and funding avenues (Global Angels)
The new board aims to work with the governments of various countries to increase cross-border investments in startups and offering greater networking and learning experiences for members. 
In addition, three new members have been elected to the Global Board of Trustees. Portland, Oregon-based Dr. Sharon Richardson Howell, Washington D.C.-based Smita Siddhanti, and Hyderabad, India-based Kali Prasad Gadiraju are the newly elected board members.
Dr. Sharon Howell is the Co-Founder and Managing Partner of Huntington Hill Ventures (HHV). Sharon has been the General Manager for Growth at ZoomCare, a Portland, Oregon-based chain of health care clinics. ZoomCare was acquired by PeaceHealth in 2018, where she was appointed SVP of Strategy, Partnerships, and Affiliations. 
Dr. Smita Siddhanti is a seasoned entrepreneur in government consulting. She was the immediate past President of the DC chapter of TiE. After a successful career with such major consulting firms as Booz Allen Hamilton, she founded EnDyna Inc., which specializes in management and environmental consulting.
Kali Prasad Gadiraju is currently the Chairman of Shihon Advisors LLP. Till recently, Kali was Office Managing Partner of Ernst and Young in Hyderabad. He has also been past President of TiE Hyderabad. 
About TiE Global
Founded in 1992, TiE Global is a not for profit organization dedicated to fostering entrepreneurship around the world. It has a presence in 60 cities across 14 countries. TiE strives to inspire entrepreneurs through mentoring, networking, education, incubating and funding programs and activities. With nearly 2000+ events organized by  Chapters each year, TiE brings together the entrepreneurial ecosystem of startups, investors, mentors and business leaders.
For more information, please visit our website at www.tie.org, or write to Aparna Mishra – aparna@tie.org.
Source: TiE Global

Global Team Enables Child With a Fatal Genetic Disease to Recover

NEW YORK (PRWEB) January 17, 2020
A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics in Riyadh, Saudi Arabia, and immunologists at the Icahn School of Medicine at Mount Sinai in New York.
A report published in The New England Journal of Medicine today describes how the global team combined exceptional supportive clinical therapy, genetic diagnosis and a novel immunotherapeutic drug known as a protein kinase inhibitor to bring the Saudi Arabian boy into full remission from his deadly disease, known as “USP18 deficiency” because it is caused by a mutation of the USP18 gene.
“The teamwork between our two institutions and others around the world is a textbook case of science without borders,” says Dusan Bogunovic, PhD, Associate Professor of Microbiology, and Pediatrics, at the Icahn School of Medicine at Mount Sinai and co-corresponding author of the study. “We showed that even with a disease like USP18 deficiency, sound clinical care and timely drug administration can rescue patients from what was previously considered a death sentence.”
USP18 (ubiquitin-specific peptidase 18) is a protein coding gene involved in immune system. It is important to regulate inflammation driven by a substance that our body normally secretes to fight off viruses, type 1 interferons. Mutations of USP18 result in an uncontrolled response to type 1 interferons, triggering IFN-I-mediated inflammation that’s lethal in utero or shortly after birth. JAK1 inhibitor drugs, like ruxolitinib, the protein kinase inhibitor given to the Saudi Arabian boy, take over the intended role of USP18, and thus have the potential for a prompt and sustained recovery by patients.
Dr. Bogunovic and his lab, widely known for their work in the field of rare inflammatory diseases in children, first described USP18 deficiency in 2016. The following year, physicians at King Saud University reached out to Mount Sinai via Paris Descartes University in France about a gravely ill young patient in their intensive care unit who appeared to have a variant of the USP18 gene. Thus began a clinical/research collaboration—which included Paris Descartes University as well as Rockefeller University in New York—in which scientists characterized in detail the molecular basis of the disease through a battery of whole exome sequencing, expression assays, protein analysis, and antibody detection. “After seeing a potential variation in the USP18 gene, we conducted a complete set of tests to determine what it meant in terms of protein function,” explains Marta Martin-Fernandez, PhD, a postdoctoral fellow at the Icahn School of Medicine and a first author of the published study, who performed many of its biochemical and genetic analyses. “Those findings confirmed for us that ruxolitinib was the appropriate treatment.”
The young patient, who had been kept alive for months through the extraordinary care of physicians led by Fahad Alsohime, MD, Assistant Professor at the College of Medicine, King Saud University, was promptly put on oral, twice-daily doses of ruxolitinib. The dosage was increased after insufficient changes were seen, and within two weeks his symptoms began to rapidly improve, allowing doctors to wean him from respiratory support. Subsequent CT and MRI imaging showed a resolution of hemorrhaging, ischemia, cellulitis of the right forearm, and hydrocephalus, a condition in which cerebrospinal fluid accumulates in the brain. After two years of follow-up in an outpatient clinic in Riyadh, and continued administration of the JAK1 inhibitor, the child remains free of clinical problems and has been given an encouraging prognosis by his physicians. He will likely have to take ruxolitinib for the rest of his life.
The success of this case has provided a further springboard for Mount Sinai scientists to investigate the genomics and molecular/cellular biology behind conditions less severe than the boy’s. This ongoing work links to other studies that have shown that JAK inhibitors—which were initially developed as anti-cancer drugs but proved to be largely ineffective—can improve symptoms and control disease activity in patients with other type 1 interferon abnormalities.
“We were able to demonstrate the benefits of rapid genetic diagnosis of an inherited disorder for which an immunosuppressant drug like ruxolitinib can provide effective and sustained treatment,” says Dr. Bogunovic of Mount Sinai, a senior author on the publication. “That kind of discovery and drug repurposing must continue to be pursued by the scientific community without interruption.”
About the Mount Sinai Health SystemThe Mount Sinai Health System is New York City’s largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai’s vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report’s “Best Medical Schools”, aligned with a U.S. News & World Report’s “Honor Roll” Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of top U.S. hospitals; it is one of the nation’s top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 “Best Hospitals” issue. Mount Sinai’s Kravis Children’s Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Luke’s and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

CCA Global Partners supports Habitat for Humanity following 2020 Winter Convention

“We really believe in caring for the community and we’re proud to support Habitat for Humanity by giving back after each of our conventions,” said CCA Global co-Founder and co-CEO Howard Brodsky.

MANCHESTER, N.H. (PRWEB) January 17, 2020
CCA Global Partners furthered its commitment to building stronger communities by donating to Habitat for Humanity this past week following its 2020 Winter Convention.
The convention draws thousands of business partners from across North America and was held in Phoenix this year. It’s tailored to CCA Global’s flooring retail cooperatives, Carpet One Floor & Home, Flooring America & Flooring Canada, and The Floor Trader. The event features a large exhibition of this season’s trendiest floor coverings — including hardwood, tile, carpet, luxury vinyl, laminate and area rugs — as well as top kitchen and bath products.
Traditionally, CCA Global donates flooring and other household items that are showcased during the exhibit to a local Habitat for Humanity ReStore at the conclusion of each convention.
“We really believe in caring for the community and we’re proud to support Habitat for Humanity by giving back after each of our conventions,” said CCA Global co-Founder and co-CEO Howard Brodsky. “Lack of affordable housing is a widespread issue around the country and it’s been wonderful to make a difference in the areas we visit.”
CCA Global was able to donate two pallets of waterproof hardwood and luxury vinyl tile, two rolls of carpet and vinyl, a table, nightstand, loveseat, side chairs and a bed.
The Habitat ReStore will take these donations and make them available to the public for a fraction of their market price. This not only helps families accomplish their home projects, but also supports Habitat for Humanity’s goal of providing safe and affordable housing.
“We appreciate the opportunity to partner with leaders in our retail world to help fulfill our mission to provide decent, affordable housing,” said Sharyn Logue, who works as the procurement manager for central Arizona’s Habitat ReStore. “Our Habitat ReStores always welcome new product and are honored to accept such incredible donations to offer to our customers.”
CCA Global’s next convention will be held in Nashville in August of 2020 where the company plans to continue its semiannual custom of donating leading flooring items to the local Habitat for Humanity ReStore. The tradition has been in place since 2007, making this the fourteenth year CCA Global has partnered with Habitat for Humanity to support local community growth.
For more information on CCA Global Partners, visit http://www.ccaglobalpartners.com.
About CCA Global PartnersCCA Global Partners, Inc. is a privately held cooperative based in the United States with member businesses in the U.S., Canada, Australia, and New Zealand. For over a quarter of a century, CCA Global has partnered with entrepreneurial businesspeople to create a cooperative powerhouse unmatched in the marketplace. With 15 independent business brands and more than 2,800 locations, CCA Global Partners is well positioned to positively impact the success of independent businesses. For more information on CCA Global Partners, go to http://www.ccaglobal.com.

Share article on social media or email:

Global Pectin Market to Register Over 7.6% CAGR Up to 2026: Global Market Insights, Inc.

Pectin Market value is expected to surpass USD $1.8 billion by 2026, owing to a growing necessity for organic and herbal cosmetic products among the young population.
SELBYVILLE, Del., January 17, 2020 (Newswire.com) – Global pectin market research studies the types of application (food & beverages: jams, dairy, non-dairy beverages, confectionery), their type (high methylated ester pectin, low methylated ester pectin, and amidated pectin), their function (gelling agents, thickener, stabilizer, fat replacer and others), regional outlook, price trends, growth potential, competitive market share and provides forecasts for 2019–2025. Global Market Insights, Inc., forecasts more than a 7.6% CAGR for the worldwide pectin industry up to 2025.
Driven by the growing need for plant-based ingredients, the global pectin market is projected to observe significant gains over the forthcoming years. Plant-based ingredients are witnessing this upsurge since they offer immense health benefits.
Request a sample of this research report at https://www.gminsights.com/request-sample/detail/4416
Pectin products help to control blood sugar levels. These products also help to maintain proper bowel health. Owing to these multiple benefits, pectin products are best suited for nutritional needs, which is likely to foster their market share in the coming years.  
Along with health concerns, rising applications of the product in confectionery fillings and sweets would possibly augment the market outlook. Additionally, the increasing usage of pectin in fruit juices and milk drinks as a stabilizer would add up to the industry’s expansion. Pectin helps decrease syneresis in marmalades and jams. 
With respect to the raw material segment, apples have dominated the market outlook in recent years. The product is anticipated to witness similar growth in the forthcoming timeframe. This development is attributed to the use of apple pomace in production. Apple peel is one of the major wastes in preserve manufacturing. This peel contains about 1.3 percent of pectin. Apple peel yields more pectin in comparison to sugar beet and citrus peels. In addition, it has better gelling characteristics which further makes it a major raw material in the beverage and food market.
With reference to the geographical landscape, the Asia-Pacific pectin market is predicted to observe significant growth throughout the forthcoming years. Rapidly transforming customer lifestyles is the key factor augmenting the market outlook in the region.
In addition, the increasing demand for consumables that are organic in nature is likely to add up to the growth of the overall market trends. China would possibly lead the market expansion in the region. The country is among the largest producers of pectin. It is also observing mounting demand for health and wellness products due to the increasingly growing middle-class population. Furthermore, rising applications of citrus-based products in the cosmetics sector would further outline the market growth in the region.
Some of the key players in the pectin market includes Cargill, Dupont, Krishna Pectins Pvt Ltd, AEP Colloids, Silvateam S.p.a, CP Kelco U.S., Inc., TIC Gums, Inc. (Ingredion), Compania Espanola de Algas Marinas, S.A., Merck KGaA, Lucid Colloids Ltd., Herbstreith & Fox, Nikunj Chemicals, Pure Ingredients, Cifal Herbal Private Ltd, California Ingredients Inc, Calleva Ingredients Limited etc.
Make an inquiry for purchasing this report at https://www.gminsights.com/inquiry-before-buying/4416
Partial Table of Contents (ToC) of the report:
Chapter 4 Pectin Market Statistics, By Type
4.1 Key product trends
4.2 High Methylated Ester Pectin4.2.1 Global high methylated ester market, 2014-2026, (Tons) (USD Million)4.2.2 Global high methylated ester market, by region, 2014-2026, (Tons) (USD Million)
4.3 Low methylated ester pectin4.3.1 Global low methylated ester market, 2014-2026, (Tons) (USD Million)4.3.2 Global low methylated ester market, by region, 2014-2026, (Tons) (USD Million)
4.4 Amidated pectin4.4.1 Global amidated market, 2014-2026, (Tons) (USD Million)4.4.2 Global amidated market, by region, 2014-2026, (Tons) (USD Million)
Browse Complete Table of Contents (ToC) at
https://www.gminsights.com/toc/detail/pectin-market
About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun HegdeCorporate Sales, USAGlobal Market Insights, Inc.Phone: 1-302-846-7766Toll-Free: 1-888-689-0688Email: sales@gminsights.com
Source: Global Market Insights, Inc.

ISPE Gathers Global Aseptic Leaders to Discuss Trends and Innovations

Now in its 29th year, this signature event has established itself as the pharmaceutical industry’s leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders.(PRWeb January 16, 2020)Read the full story at https://www.prweb.com/releases/ispe_gathers_global_aseptic_leaders_to_discuss_trends_and_innovations/prweb16834125.htm